Skip to the content.

September 4, 2022 Analysis of US state data

This report shows the result of analyses that use hospital admission data to estimate the transmission rates in the past few months to characterize the recent Omicron waves. Hospital admission data are used, to avoid testing capacity issues and to better predict future hospital admission rates.

The modelling approach for US states has now changed to follow the approach first applied in July for European nations. See this link for more information.

The European nations in the study were chosen for the distinct BA.2 wave which allowed critical aspects of population-level immunity to be measured from the data:

Few US states had a distinct BA.2 wave, and so the identical approach cannot be applied. Instead, information from the previous models (that included the entire time history) was transferred to the new models that contain now history prior to 2022, and mimic the initial population immunity as arising from natural infections occuring near the beginning of 2022. Since the turnover of waves results from the growth in immunity from infections, the rate to which immunity grows is effectively measured by fit of the model parameters to the data, assuming constant transmission rates.

As seen in the recent European analyses, immunity waning appears to be a significant effect, and the same waning parameters are fit in the US data. Given the lack of the well established BA.2 wave to calibrate immunity, the waning parameter estimates may not be directly comparable to those from Europe.

In the figures below, the small dots show daily values, and the larger circles are weekly averages to help guide the eye. There are no changes to transmission rates (normally shown by dashed vertical lines) within the time periods shown below. Each strain has just 2 parameters (transmission rate and timing).

Individual state hospitalization analyses

The plots for each state below show the daily hospital admissions and deaths since April on a linear scale (left) and log scale (right). Cases are also included on the right. BA.4 and BA.5 are combined into one strain, labelled BA.5. For some states, the combination of BA.2, BA.4 and BA.5 are combined in one strain, labelled BA.5.

The projections below show a significant resurgance for some states. These are not definitive predictions, but instead is an indication of the sensitivity on the degree to which immunity wanes, which is not yet well established.

Alaska

ak

Alabama

al

Arkansas

ar

Arizona

az

California

ca

Colorado

co

Connecticut

ct

District Of Columbia

dc

Delaware

de

Florida

fl

Georgia

ga

Hawaii

hi

Iowa

ia

Idaho

id

Illinois

il

Indiana

in

Kansas

ks

Kentucky

ky

Louisiana

la

Massachusetts

ma

Maryland

md

Maine

me

Michigan

mi

Minnesota

mn

Missouri

mo

Mississippi

ms

Montana

mt

North Carolina

nc

North Dakota

nd

Nebraska

ne

New Hampshire

nh

New Jersey

nj

New Mexico

nm

Nevada

nv

New York

ny

Ohio

oh

Oklahoma

ok

Oregon

or

Pennsylvania

pa

Puerto Rico

pr

Rhode Island

ri

South Carolina

sc

South Dakota

sd

Tennessee

tn

Texas

tx

Utah

ut

Virginia

va

Vermont

vt

Washington

wa

Wisconsin

wi

West Virginia

wv

Wyoming

wy

return to case studies